Basic information Safety Supplier Related

RUBOXISTAURIN HYDROCHLORIDE

Basic information Safety Supplier Related

RUBOXISTAURIN HYDROCHLORIDE Basic information

Product Name:
RUBOXISTAURIN HYDROCHLORIDE
Synonyms:
  • Ruboxistaurin Hydrochloride
  • (9S)-9-[(DiMethylaMino)Methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-DiMethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione Hydrochloride
  • (S)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione monohydrochloride
  • Ruboxistaurin HCl
  • Ruboxistaurin(LY333531HCl)
  • LY 333531 hydrochloride - Ruboxistaurin
  • Ruboxistaurin hydrochloride (LY333531)
  • Ruboxistaurin HCl(LY333531 )
CAS:
169939-93-9
MF:
C28H29ClN4O3
MW:
505.02
Product Categories:
  • Amines
  • Heterocycles
  • Inhibitors
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
Mol File:
169939-93-9.mol
More
Less

RUBOXISTAURIN HYDROCHLORIDE Chemical Properties

alpha 
D25 -28.7° (c = 1.0 in ethanol)
storage temp. 
Inert atmosphere,Store in freezer, under -20°C
solubility 
DMSO: soluble10mg/mL, clear
form 
powder
color 
orange-red
More
Less

Safety Information

WGK Germany 
3
More
Less

RUBOXISTAURIN HYDROCHLORIDE Usage And Synthesis

Description

LY333531 is an inhibitor of PKCβ (IC50s = 4.7 and 5.9 nM for PKCβ1 and PKCβ2, respectively). It is selective for PKCβ1 and PKCβ2 over PKCα, -γ, -δ, -ε, -ζ, and -η (IC50s = 360, 300, 250, >100,000, and 52 nM, respectively). LY333531 also inhibits glycogen synthase kinase 3β (GSK3β; IC50 = 39.4 nM). It inhibits neutrophil extracellular trap (NET) formation induced by phorbol 12-myristate 13-acetate (PMA; ) in primary human neutrophils when used at a concentration of 1 μM. LY333531 increases the mechanical nociceptive threshold in a rat model of diabetic hyperalgesia induced by streptozotocin (STZ; ).

Uses

A protein kinase C (PKC) β inhibitor, exhibits significant anti-angiogenic activity that reduces the response of vascular endothelial cells to stimulation by vascular endothelial growth factor (VEGF). It is used in treatment of diabetic microvascular comp

Uses

Ruboxistaurin is a protein kinase C (PKC) β inhibitor, exhibits significant anti-angiogenic activity that reduces the response of vascular endothelial cells to stimulation by vascular endothelial growth factor (VEGF). Ruboxistaurin is used in treatment of diabetic microvascular complications.

RUBOXISTAURIN HYDROCHLORIDESupplier

ShangHai ChuanQian Chemcial Technique Centre Gold
Tel
15869524721
Email
3525679403@qq.com
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
ChemCell Biomedicine Co.,Ltd.
Tel
020-13556033878 2965585218 13556033878
Email
chemcell@hotmail.com
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Email
info@chemexpress.com